Skip to main content

Featured Stories

Commentary
May 05, 2021
In this week’s issue of Talking Therapeutics, Dr Jennings explores a new drug approval and what it means for patients with chronic kidney disease.
Commentary
May 04, 2021
“Goal-directed use of antihypertensives and statin drugs appear to be effective strategies to reduce atrial fibrillation incidence, morbidity, and…
News
May 03, 2021
More than 200,000 doses of the COVID-19 vaccine have gone to waste since December, and according to government data, two national pharmacy chains…
News
April 28, 2021
A female hormone used to reduce menopause symptoms in women is under a Class II recall.
News
April 28, 2021
A recall is active for a prescription steroid used to treat a variety of skin conditions, such as eczema, dermatitis, and allergies.
News
April 28, 2021
Sterility concerns due to defective containers have prompted Edge Pharma to voluntarily recall 5850 syringes of Betadine (povidone iodine) ophthalmic…
Commentary
April 28, 2021
In this week’s issue of Talking Therapeutics, Dr Jennings explores the science and promise of a recently approved novel medication for patients with…
Commentary
April 20, 2021
Dr Jennings reviews evidence supporting colchicine use to further reduce residual disease burden in coronary artery disease but highlights why…
Commentary
April 20, 2021
“Health care providers can be instrumental in recognizing and helping patients suffering with mental health issues by keeping the lines of…
Back to Top